MDxHealth is trading 11.22% up at $0.67 after no clear company-specific catalyst was identified for September 22, 2026.

  • Available coverage found no announcement, earnings release, regulatory action, or analyst catalyst explaining the move.
  • Broader markets are mixed, with only modest index changes.
  • The pre-market gain remains unexplained and may reflect limited liquidity or delayed trading activity.